367 related articles for article (PubMed ID: 29521664)
1. New and emerging therapies in treatment of Clostridium difficile infection.
Goyal H; Perisetti A; Rehman MR; Singla U
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
[TBL] [Abstract][Full Text] [Related]
3. Management of adult Clostridium difficile digestive contaminations: a literature review.
Mathias F; Curti C; Montana M; Bornet C; Vanelle P
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):209-231. PubMed ID: 30498879
[TBL] [Abstract][Full Text] [Related]
4. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
Manthey CF; Eckmann L; Fuhrmann V
Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
[TBL] [Abstract][Full Text] [Related]
5. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
[TBL] [Abstract][Full Text] [Related]
6. Current advances related to Clostridium difficile infection.
Kim YG; Jang BI
Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection: review.
Czepiel J; Dróżdż M; Pituch H; Kuijper EJ; Perucki W; Mielimonka A; Goldman S; Wultańska D; Garlicki A; Biesiada G
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1211-1221. PubMed ID: 30945014
[TBL] [Abstract][Full Text] [Related]
8. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF
Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862
[TBL] [Abstract][Full Text] [Related]
9. [Individualized treatment strategies for Clostridium difficile infections].
Solbach P; Dersch P; Bachmann O
Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
[TBL] [Abstract][Full Text] [Related]
10. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of Clostridium difficile infection.
Korman TM
Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
[TBL] [Abstract][Full Text] [Related]
12. Differences of the Fecal Microflora With Clostridium difficile Therapies.
Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
[TBL] [Abstract][Full Text] [Related]
13. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA
J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856
[TBL] [Abstract][Full Text] [Related]
16. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
Li R; Lu L; Lin Y; Wang M; Liu X
PLoS One; 2015; 10(10):e0137252. PubMed ID: 26444424
[TBL] [Abstract][Full Text] [Related]
18. Challenges and opportunities in the management of Clostridium difficile infection.
DuPont HL
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
[TBL] [Abstract][Full Text] [Related]
20. Current strategies for management of initial Clostridium difficile infection.
Kelly CP
J Hosp Med; 2012 Mar; 7 Suppl 3():S5-10. PubMed ID: 22407996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
